skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: In my opinion the U.S. China trade relations will soon improve. One reason being Trump does not want to go into an election without the economy firing on all cylinders. Can you suggest a stock that will benefit from the easing of trade barriers.
Read Answer Asked by Brian on November 18, 2019
Q: Just wondering what the expectations are for AYX next quarter. Looking at the past few quarters, the year over year comparison is going to be tough, given that last year's revenues almost doubled; December 2018. I never did figure out how much of this is related to changes in accounting standards for recognizing revenue. Any comments appreciated.
Read Answer Asked by Leo on November 18, 2019
Q: This name came up last week. I was interested in it but didn’t buy it because I was worried that smart TVs would make the Roku devices unnecessary. Is that not a concern? I see that Roku also now sells smart TVs so perhaps that’s the answer. Also, how does one know when a stock like this has become over valued? How much run way do you see in this name for future appreciation? Thanks as always.

Jason
Read Answer Asked by Jason on November 18, 2019
Q: I am seeing Buy ratings if not top picks on Boeing and wonder what 5i thinks about it. My question is whether or not you think most of the downside is priced in? What could cause a plunge (another accident obviously) but would a huge lawsuit against the company be something that isn't priced in? I have to think a leg up will occur when the Max 8 lifts off again. Please advise if you would buy and whether you agree with the thoughts above.
Read Answer Asked by Tim on November 15, 2019
Q: Hi 5i team,

Back to AMRN. I thought they hit a home run yesterday with a unanimous (16 to 0) vote of the Advisory Committee to approve an expanded label use of Vascepa for treating various heart-related conditions, which should give them access to a much larger patient population base. However, the market is not so sure as the response is very muted at least so far today, and that may change. I took a small position to manage risk as I expected a big move one way or the other. I recognize this still has to go to the full FDA in a few weeks, but I understand that the FDA seldom overturns a strong endorsement of the AdCom. Am I missing something here in the muted market response?

Thanks again.
Dave
Read Answer Asked by Dave on November 15, 2019
Q: I see Lithium and related stocks have taken quite a beating as supply has overstripped demand. However long term growth in electric car and required batteries seems to bode well for the industry. Any lithium stocks you recommend at this time for a longer term hold? Prefer companies with production or close to versus speculative...
Read Answer Asked by John on November 15, 2019
Q: On the US side, we've owned TOT, CSCO, MO and PM for some time now and they have languished. Is patience merited or should I sell these positions and replace them with other US stocks? We're retired and want to preserve capital but do like dividend income. thanks
Read Answer Asked by alex on November 14, 2019
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!